Undermining Access to Medicines: Comparison of five US FTAs: A technical note

Publication date

01 Jun 2004


Share publication

The US government is using bilateral and regional free-trade agreements (FTAs) to impose unnecessarily stringent intellectual property standards on developing countries that go beyond even the damaging requirements of World Trade Organisation (WTO) rules. These new higher standards favour the short-term commercial interests of US pharmaceutical companies, at the expense of public health in developing countries.